Clinical Trial Update: Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating nausea outcomes in patients receiving hydromorphone versus oxycodone after total hip replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Hydromorphone (hydromorphone)
• Oxycodone (oxycodone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Nausea | Phase 4 | Status: COMPLETED